Ovarian conservation at the time of hysterectomy for benign disease

Obstetrics and Gynecology

Volumn 106, Issue 2, 2005, Pages 219-226

  Parker, William H ^a   Broder, Michael S ^a   Liu, Zhimei ^a   Shoupe, Donna ^a   Farquhar, Cindy ^a   Berek, Jonathan S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; CANCER RISK; CARDIOVASCULAR RISK; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HIP FRACTURE; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; NORMAL HUMAN; ORGAN PRESERVATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK REDUCTION; STROKE; SURVIVAL RATE; TREATMENT INDICATION;

EID: 22544477066     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000167394.38215.56     Document Type: Article

References (45)

1. Keshavarz H, Hillis S, Kieke B, Marchbanks P. Hysterectomy surveillance-United States, 1994-1999. MMWR CDC Surveill Summ 2002;51:1-8. Available at: http://www.cdc.gov/mmwr/PDF/ss/ss5105.pdf. Retrieved April 26, 2005.
2. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin 7. Washington, DC: ACOG; 1999.
3. Hankinson SE, Hunter DJ, Colditz GA, Willett WC, Stampfer MJ, Rosner B, et al. Tubal ligation, hysterectomy, and risk of ovarian cancer: a prospective study. JAMA 1993;270:2813-8.
4. Loft A, Lidegaard O, Tabor A. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. Br J Obstet Gynaecol 1997;104:1296-301.
5. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-203.
6. Kreiger N, Sloan M, Cotterchio M, Parsons P. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol 1997;26:710-5.
7. Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991;134:362-9.
8. Judd HL, Judd GE, Lucas WE, Yen SS. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020-4.
9. Bhavnani V, Clarke A. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy. BJOG 2003;110:168-74.
10. Armstrong K, Schwartz J, Randall T, Rubin S, Weber B. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol 2004;22:1045-54.
11. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-38.
12. Harris R, Helfand M, Woolf S, Lohr KN, Mulrow CD, Teutsch SM, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20 suppl:21-35.
13. SEER 12 incidence and mortality, 1993-2001, follow-back year 1992. Surveillance, Epidemiology, and End Results (SEER) Program. DevCan database. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2004.
14. CDC/NCHS, National Vital Statistics System, Table HIST002R_2. Death rates from 113 selected causes, by 5-year age groups, race and sex: United States, 1979-1998. Ischemic heart disease (410-414, 429.2), all races, female, 1998. p. 336. Available at: http://www.cdc.gov/nchs/data/statab/hist002r_2.pdf. Retrieved April 26, 2005.
15. Huang Z, Himes J, McGovern P. Nutrition and subsequent hip fracture risk among a national cohort of white women. Am J Epidemiol 1996;144:124-34.
16. Karagas MR, Lu-Yao GL, Barrett JA, Beach ML, Baron JA. Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am J Epidemiol 1996;143:677-82.
17. Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ 1993;307:1248-50.
18. CDC/NCHS, National Vital Statistics System, Table HIST002R_2. Death rates from 113 selected causes, by 5-year age groups, race and sex: United States, 1979-1998. Cerebrovascular disease (430-434, 436-438), all races, female, 1998. p. 408. Available at: http://www.cdc.gov/nchs/data/statab/hist002r_2.pdf. Retrieved April 26, 2005.
19. Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD. Deaths: Final Data for 2001. Natl Vital Stat Rep 2003;52: 1-115.
20. Purdie DM, Bain CJ, Siskind V, Russell P, Hacker NF, Ward BG, et al. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer 1999;81:559-63.
21. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-10.
22. Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 2000;53:832-7.
23. Rosenberg L, Hennekens C, Rosner B, Belanger C, Rothman K, Speizer F. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981;139:47-51.
24. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol 1992;136: 408-16.
25. van der Schouw YT, van der Graa Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714-8.
26. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative Randomized Controlled Trial. The Women's Health Initiative Steering Committee. JAMA 2004;291:1701-12.
27. Melton LJ 3rd, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 2003;18:900-5.
28. Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton L. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 1997;70:150-4.
29. National Inpatient Sample of the HCUP database of the Agency for HealthCare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/ nisoverview.jsp. Retrieved April 26, 2005.
30. Dekel A, Efratz Z, Orvieto R, Levy T, Dicker D, Gal R, et al. The residual ovary syndrome: a 20 year experience. Eur J Obstet Gynecol Reprod Biol 1996;68:159-64.
31. Whittemore AS, Wu ML, Paffenbarger RS Jr, Sarles DL, Kampert JB, Grosser S, et al. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 1988;128:1228-40.
32. Yang HJ, Liu VW, Tsang PC, Yip AM, Ng TY, Cheung AN, Ngan HY. Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development. Tumour Biol 2003;24:310-6.
33. Sluijmer A, Heineman M, De Jong F, Evers J. Endocrine activity of the postmenopausal ovary: the effect of pituitary down-regulation and oophorectomy. J Clin Endocrinol Metab 1995;80:2163-7.
34. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976;42:247-53.
35. Hsia J, Barad D, Margolis K, Rodabough R, McGovern P, Limacher M, et al. Usefulness of prior hysterectomy as an independent risk predictor of Framingham risk score (the Women's Health Initiative). Am J Cardiol 2003;92:264-9.
36. Stoney CM, Owens JF, Guzick DS, Matthews KA. A natural experiment on the effects of ovarian hormones on cardiovascular risk factors and stress reactivity: bilateral salpingo oophorectomy versus hysterectomy only. Health Psychol 1997;16: 349-58.
37. Wuest JH Jr, Dry TJ, Edwards JE. The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circulation 1953;7:801-9.
38. Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 2004;82:391-7.
39. Hodis H, Mack W. Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 2002;89:19E-27E.
40. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 1998; 339:733-8.
41. Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 1982;54:115-20.
42. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878-82.
43. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20S-26S.
44. Buist DS, Newton KM, Miglioretti DL, Beverly K, Connelly MT, Andrade S, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042-50.
45. Speroff T, Dawson N, Speroff L, Haber R. A risk-benefit analysis of elective bilateral oophorectomy: effect of changes in compliance with estrogen therapy on outcome. Am J Obstet Gynecol 1991;164:165-74.